Early Detection Isn’t Enough: How Experts Are Changing the Future of Cancer Care

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/bc/b7/29/bcb729f1-9667-f7e9-e2ed-0ae10f37875c/mza_4597590311461697087.jpg/600x600bb.jpg

All Things Cancer | National Foundation for Cancer Research

National Foundation for Cancer Research

12 episodes

6 days ago

Join Dr. Sujuan Ba, the CEO of the National Foundation for Cancer Research, as she sits down with leading scientists, advocates, researchers, and patients who are shaping the future of cancer research and care. In each episode, Dr. Ba explores the groundbreaking work, personal stories, and transformative ideas driving the fight against cancer. From cutting-edge discoveries in the lab to the inspiring resilience of patients and advocates, All Things Cancer offers a unique perspective on the journey to cures and better lives for those impacted by cancer.

Non-Profit

Business

RSS

All content for All Things Cancer | National Foundation for Cancer Research is the property of National Foundation for Cancer Research and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Non-Profit

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40253013/40253013-1742927031721-4fc7c6b060ea8.jpg

Early Detection Isn’t Enough: How Experts Are Changing the Future of Cancer Care

All Things Cancer | National Foundation for Cancer Research

30 minutes 44 seconds

3 months ago

Early Detection Isn’t Enough: How Experts Are Changing the Future of Cancer Care

In this powerful episode of All Things Cancer, host Dr. Sujuan Ba convenes some of the most forward-thinking voices in oncology to explore how early detection and early intervention are reshaping the future of cancer care. Featuring insights from Dr. Siddhartha Mukherjee, Dr. Samir Hanash, Dr. Steven Lipkin, Dr. Sapna Syngal, Dr. Ajay Goel, and Dr. Carlos Doti, this conversation—originally recorded during the 2024 NFCR Global Summit—dives into breakthroughs in biomarkers, liquid biopsies, genetic risk modeling, cancer interception, and how equitable access remains the key to meaningful progress.

From the lab bench to real-world implementation, this episode reveals how science, strategy, and compassion must align to truly reduce cancer mortality.

Original music featured in this episode is composed and performed by David Tolk.
Explore more of his work at: www.youtube.com/@DavidTolkMusic